Decision (EU) 2018/1463 on subjecting the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl to control measures

Summary:

On 30 April 2018 the European Commission presented a proposal for a Council Implementing Decision on subjecting two new psychoactive substances to control measures. The Council of the European Union adopted the Decision on 28 September 2018.

Further information:

In January 2018 the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) and the possible consequences of control measures introduced on these substances.

The risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), and risk assessment reports were submitted to the Commission and to the Council on 23 March 2018.

According to the risk assessment reports, the acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl can cause severe harm to the health of individuals. The Commission therefore considers that there are grounds for subjecting these substances to control measures across the Union.

EUR-Lex: COM(2018)253: Proposal for a Council Implementing Decision on subjecting the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl to control measures https://eur-lex.europa.eu/legal-content/EN/HIS/?uri=COM:2018:253:FIN

---